Research article · 2017
Conference abstractPublished 23 Jul 2018
Efficacy and tolerability of fixed dose combination of nadifloxacin and adapalene gel for the treatment of acne vulgaris: A phase III randomized multicenter study in India
J. Medical College, India; Wockhardt Ltd, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Acne vulgaris is a chronic inflammatory disease. The multifactorial etiology of acne vulgaris makes it challenging to treat. Antimicrobials should be combined with topical retinoids for greater clearing of lesions and shortened duration of antibiotic treatment. Aim: The present study compared the efficacy and safety of nadifloxacin and adapalene fixed dose combination (FDC) gel with adapalene monotherapy and nadifloxacin monotherapy. Method: It was a randomized, double blind, controlled, multicentre, phase III, parallel group study conducted in India. In this eightweek study, 318 patients with mild to moderate acne were randomly allocated to either of the three treatment groups; Group A (morning placebo, evening FDC; FDC of nadifloxacin 1% + adapalene 0.1%, n=106), Group B (morning placebo, evening adapalene 0.1%, n=106) and Group C (twice daily nadifloxacin 1% alone, n=106). The outcome variables included lesion counts, acne severity based on investigator global assessment (IGA) scale and quality of life (QOL) assessment. Adverse events (AEs) were recorded at every visit. Findings: At the end of the treatment, maximum mean reduction in inflammatory lesion counts were comparable in Group A (-11.1) in comparison to Group B (-8.9) and Group C (-8.5); p>0.05 for both. However, change from baseline in non-inflammatory lesion count at week eight was higher in Group A (-13.1) compared to Group B (-12.0); p=0.04 and Group C (-11.5), p =0.17. For acne severity, 61.7% of patients in Group A, 54.3% in Group B and 56% in Group C showed improvement. The maximum improvement in terms of quality of life (QOL) score was observed in Group A; with comparable results for the other group. Conclusion: Topical fixed dose combination of nadifloxacin 1% and adapalene 0.1% is effective in mild to moderate acne with good tolerability. Recent Publications: 1. Stein Gold L, Baldwin H E and Lin T (2017) Management of severe acne vulgaris with topical therapy. Journal of Drugs in Dermatology: JDD 16(11):1134â??8. 2. Kaur J, Sehgal V K, Gupta A K and Singh S P (2015) A comparative study to evaluate the efficacy and safety of combination topical preparations in acne vulgaris. International Journal of Applied and Basic Medical Research 5(2):106. 3. Shah B J, Sumathy T K, Dhurat R S, Torsekar R G, Viswanath V, et al. (2014) Efficacy and tolerability of topical fixed combination of nadifloxacin 1% and adapalene 0.1% in the treatment of mild to moderate acne vulgaris in Indian patients: a multicenter, open-labelled, prospective study. Indian Journal of Dermatology 59(4):385â??9. 4. S Choudhury, S Chatterjee, D K Sarkar and R N Dutta (2011) Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial. Indian Journal of Pharmacology 43(6):628. 5. Kobayashi M, Nakagawa T, Fukamachi K, Nakamura M and Tokura Y (2011) Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study. The Journal of Dermatology 38(12):1163â??6.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 21 Aug 2019
Efficacy and Tolerability of a Tretinoin 0.02%, Clindamycin 0.8% and Glycolic Acid 4% Gel in Acne: A Multicenter, Prospective, Pragmatic, Assessor-Blinded, 12-Week Trial on 159 Subjects
Conference abstract · 2012
Long term efficacy and tolerability of a combined topical therapy of Sodium L-ascorbyl-2- phosphate 5% lotion and Adapalene 0.3% gel for Acne Vulgaris in comparison with monotherapy
Conference abstract · 9 Apr 2020
Parallel Topical Treatment of Adult Acne vulgaris Patients with Nadifloxacin Cream and Adapalene
Conference abstract · 25 Apr 2016
Long maintenance therapy, more than 2 years of sodium L-ascorbyl-2-phosphate, for moderate to severe acne in comparison with 0.1% adapalene gel
More from this journal
The newest in Journal of Clinical & Experimental Dermatology Research.
Research article · 30 Jul 2026
MINIMALLY-INVASIVE LASER-ASSISTED (MILA) FACELIFT UNDER LOCAL ANESTHESIA
Commentary · 30 Jul 2026
Breaking the Stigma Around Psoriasis: A Broader View of Chronic Skin Disease
Perspective · 28 Jul 2026
Acne as More Than a Cosmetic Concern: A Personal and Medical Perspective
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Dermatology Research
- SubjectDermatology
- BylineArticles whose byline prints “Bela Shah”
- BylineArticles whose byline prints “Rishi Jain”
- BylineArticles whose byline prints “Agam Shah”
- BylineArticles whose byline prints “Vaibhavi Kapatkar”
- BylineArticles whose byline prints “Roheet Rathod”
- BylineArticles whose byline prints “Salman Motlekar”
- BylineArticles whose byline prints “Lyndon Dsouza”

